Back to discover
Drug
Trimethylamine
Research stageEmerging research
2
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Research2024-04-01Postgraduate medical journal
Dietary lipids, gut microbiota and lipid metabolism.
Research2019-12-01Reviews in endocrine & metabolic disorders
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Trimethylamine
RxNorm CUI
1999994
ChEMBL ID
CHEMBL439723
UNII
LHH7G8O305
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Publications over time
20192024
Most influential
Major research themes3
Gastrointestinal Microbiome1Methylamines1Nervous System Diseases1
Journals, researchers & institutions
Top journals
- Postgraduate medical journal1
- Reviews in endocrine & metabolic disorders1
Leading researchers
- Caesar R1
- Cheng H1
- Liu B1
- Mao X1
- Pan L1
- Schoeler M1
- Xie L1
Leading institutions
free-text, unnormalised
- Beijing Key Laboratory of Central Nervous System Injury1
- Beijing TianTan Hospital1
- China National Clinical Research Center for Neurological Diseases1
- The First Affiliated Hospital of Anhui Medical University1
- The First People's Hospital of Tianshui1
- The Wallenberg Laboratory1
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature